Viewing Study NCT03106233


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-01-07 @ 1:29 PM
Study NCT ID: NCT03106233
Status: COMPLETED
Last Update Posted: 2017-04-10
First Post: 2017-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction
Sponsor: Maastricht University Medical Center
Organization:

Study Overview

Official Title: The Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction: A Prospective Analysis of 138 Flaps
Status: COMPLETED
Status Verified Date: 2017-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The lateral thigh perforator (LTP) flap was previously introduced as an alternative flap for autologous breast reconstruction when the abdomen is not suitable as a donor site. In this prospective study all LTP flap breast reconstructions that have been performed since September 2012 are analyzed. In addition, the surgical refinements that were introduced over the years are reported.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: